Boxing Day: 3 TSX Stocks That Are on Sale

A gloomy Boxing Day in 2020 should inspire Canadians to hunt undervalued TSX stocks like Canadian Western Bank (TSX:CWB) and others today.

| More on:

Boxing Day has arrived across Canada. This may be the quietest day for foot traffic in retailers and malls since post-Christmas Boxing Day sales were conceptualized. Retailers are a risky bet right now, but Canadian investors should not turn away from the red-hot market entirely. Today, I want to look at three TSX stocks that offer attractive value as we look ahead to the new year. Let’s jump in.

TSX stock on sale: A housing dividend star to stash right now

Genworth MI Canada (TSX:MIC) is the first Boxing Day TSX stock on sale that I want to zero in on today. This company is the largest private residential mortgage insurer in Canada. The pandemic has wreaked havoc on several sectors. In the spring, some analysts predicted that housing would take a major hit. Those who stuck with Canada’s resilient housing sector have been rewarded. Sales and prices erupted in the spring and summer.

Shares of Genworth have climbed 29% over the past three months as of close on December 23. The stock is still down 11% in 2020. Net income rose 12% year over year to $124 million in the third quarter. Moreover, transactional premiums surged from the prior year on the back of a resurgence for the domestic real estate market.

This TSX stock last possessed an attractive price-to-earnings (P/E) ratio of nine and a price-to-book (P/B) value of one. Genworth offers a quarterly dividend of $0.54 per share, representing a solid 4.9% yield. Value investors can’t ignore Genworth on Boxing Day.

Why investors should be targeting healthcare stocks before 2021

This week, I’d recommended investors follow Warren Buffett’s lead and snag promising healthcare stocks. VieMed Healthcare (TSX:VMD) is a top TSX stock in the healthcare space. The company provides in-home durable medical equipment and healthcare solutions to patients across the United States. Its shares have increased 26% in 2020. Shares have dropped 14% month over month.

VieMed has lent its hand to the public and private sector during the pandemic. It possesses expertise in treating respiratory illnesses and is a well-known ventilator supplier. This meant it had specialized services to offer in this crisis. In Q3 2020, VieMed pointed out that the pandemic had contributed between $5 million and $6 million to its total revenue.

Best of all, this TSX stock has a favourable P/E ratio of 11. VieMed looked like a promising add before the pandemic. It is a must-add in this environment.

One more TSX stock with a fantastic history to add

Financials struggled early in 2020, as uncertainty shook the market. Fortunately, Canadian bank stocks have managed to recoup nearly all losses from the early part of the year. Canadian Western Bank (TSX:CWB) is a top regional bank. It does not offer the size or reach of its Big Six counterparts. However, what it lacks in those areas it makes up for in its dividend history.

This TSX stock has climbed 10% over the past three months. In Q4 2020, the bank saw total revenue rise 7% year over year to $237 million. Loans and bank-raised deposits increased 2% and 4%, respectively, over the previous quarter. Canadian Western Bank possesses a good P/E ratio of 10 and a P/B value of 0.9.

In Q4 2020, Canadian Western Bank announced a quarterly dividend of $0.29 per share. That represents a 4% yield. It has delivered dividend growth for 28 consecutive years. Forget the Big Six, Canadian Western is a TSX stock worth holding for the long haul.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Viemed Healthcare Inc.

More on Investing

Blocks conceptualizing Canada's Tax Free Savings Account
Investing

3 Canadian Stocks to Consider Adding to Your TFSA in 2025

Given the uncertain outlook, investors can strengthen their Tax-Free Savings Accounts by adding defensive stocks.

Read more »

Hourglass and stock price chart
Stocks for Beginners

How 2 Stocks Could Turn $10,000 Into $100,000 by 2030

The strong fundamental outlook of these two Canadian growth stocks could significantly multiply their value over the next several years.

Read more »

data analyze research
Bank Stocks

TD Bank: Buy, Sell, or Hold in 2025?

TD stock is down about 12% in 2024. Is it now oversold?

Read more »

space ship model takes off
Stock Market

The Year Ahead: Canadian Stocks With Strong Momentum for 2025

Bank of Montreal (TSX:BMO) stock is just one of many high-momentum value plays worth buying with both hands!

Read more »

rising arrow with flames
Tech Stocks

1 Canadian Stock Ready to Surge in 2025 and Beyond

Finding a great, essential AI stock isn't hard. In fact, this one has a healthy balance sheet, strong growth, and…

Read more »

ETF chart stocks
Investing

Here Are My 2 Favourite ETFs for 2025

These are the ETFs I'll be eyeballing in the New Year.

Read more »

money goes up and down in balance
Dividend Stocks

This 6% Dividend Stock Is My Top Pick for Immediate Income

This Canadian stock has resilient business model, solid dividend payment and growth history, and a well-protected yield of over 6%.

Read more »

Canadian energy stocks are rising with oil prices
Energy Stocks

Outlook for Cenovus Energy Stock in 2025

A large-cap energy stock and TSX30 winner is a screaming buy for its bright business outlook and visible growth potential.

Read more »